Common, Yet Overlooked Skin Conditions
Dermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen …
Dermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen … 
Managing acne effectively requires a nuanced approach that combines cutting-edge innovations with tried-and-true clinical strategies. In a recent presentation at the ODAC Dermatology Conference, Dr. Hilary Baldwin, MD, FAAD—Medical Director of The Acne Treatment and Research Center and Clinical Associate Professor at Rutgers Robert Wood Johnson Medical Center—shared her clinical expertise on m … 
A 16 year old patient returns to clinic after spending spring break in Miami complaining of separation of his nails from his nail bed. He also has a sunburn. The patient has erythematous comedones and pustules on his cheeks, forehead, chin and upper back [see photo], and was started on treatment for these findings at his last visit. Which of the following most likely caused his nail findings?
… 
Managing rosacea requires moving beyond quick, symptomatic fixes toward a comprehensive framework that addresses the entire scope of the disease. In a recent presentation, Adam Friedman, MD, FAAD—Professor and Chair of Dermatology at The George Washington University School of Medicine & Health Sciences—outlined an updated clinical approach to diagnosing and managing rosacea. From recognizi … 
The weight loss benefits of GLP-1 agonists have long been established, yet could these drugs have a secondary anti-inflammatory impact? Steven Daveluy, MD, FAAD, director of the Wayne State Dermatology Residency Program, gives the latest in GLP-1s in the treatment of hidradenitis suppurativa (HS) and psoriasis, in this Next Steps in Derm video interview, conducted in partnership with the ODAC Derm …